查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1605916

标的蛋白质分解市场，规模，占有率，趋势，产业分析报告:各类型，各治疗领域，各给药途径，各地区 - 市场预测 2025年～2034年

Targeted Protein Degradation Market Size, Share, Trends, Industry Analysis Report: By Type, Therapeutic Area, Route of Administration, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，到2034年，全球目标蛋白降解市场规模预计将达到35.4791亿美元。该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

由于精准医疗的进步和生物技术投资的增加，标靶蛋白质降解 (TPD) 市场正在经历显着成长。一个关键的推动因素是 TPD 能够靶向以前 "无法治疗" 的蛋白质，为癌症和神经退化性疾病等复杂疾病开闢新的治疗途径。

随着製药公司与学术机构和高科技公司合作开发新型降解剂，预计在预测期内这一市场开发机会将会增加。个人化医疗的新兴趋势和对小分子疗法的日益关注也推动了市场需求。总体而言，由于研究活动和临床试验的增加，TPD 市场预计将迅速扩大。

靶向蛋白质降解市场报告亮点

按类型划分，市场以蛋白质降解靶向嵌合分子 (PROTAC) 领域为主，该领域因其可降解多种蛋白质而被广泛采用。预计德格罗酰亚胺将在小分子疗法的进步的推动下实现快速增长。

从治疗领域来看，癌症疾病领域所占占有率最大，因为癌症治疗很大程度上依赖于标靶蛋白的降解。由于对阿兹海默症等神经退化性疾病的研究不断增加，神经系统疾病领域预计将快速成长。

从给药途径来看，静脉给药在市场上占据主导地位。静脉给药特别用于需要直接和受控递送的治疗。

北美以强大的研发活动和药品投资引领 TPD 市场。由于医疗保健支出增加、生物技术领域成长以及对创新治疗的日益关注，亚太地区成为成长最快的地区。

市场上的主要参与者包括 Arvinas、Kymera Therapeutics 和 Nurix Therapeutics。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球标的蛋白质分解市场洞察

  • 市场概述
  • 标的蛋白质分解市场动态
    • 促进因素和机会
      • 扩大肿瘤学应用
      • 增加神经系统疾病治疗
    • 阻碍因素和挑战
      • 药物开发与临床验证的复杂性
  • PESTEL分析
  • 标的蛋白质分解市场应用趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球标的蛋白质分解市场:各类型

  • 主要调查结果
  • 简介
  • Degronimids
  • 免疫调节药(IMiD)
  • 蛋白质分解标的嵌合体分子(PROTAC)
  • 突发性视网膜变性症候群(SARD)
  • 选择的雌激素受体分解药(SERD)
  • 其他

第6章 全球标的蛋白质分解市场:各治疗领域

  • 主要调查结果
  • 简介
  • 发炎性疾病
  • 神经疾病
  • 肿瘤性疾病
  • 呼吸疾病
  • 其他

第7章 全球标的蛋白质分解市场:各给药途径

  • 主要调查结果
  • 简介
  • 口服
  • 静脉内
  • 其他

第8章 全球标的蛋白质分解市场:各地区

  • 主要调查结果
  • 简介
    • 标的蛋白质分解市场评估:各地区，2020～2034年
  • 北美
    • 北美:各类型，2020～2034年
    • 北美:各治疗领域，2020～2034年
    • 北美:各给药途径，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各类型，2020～2034年
    • 欧洲:各治疗领域，2020～2034年
    • 欧洲:各给药途径，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各类型，2020～2034年
    • 亚太地区:各治疗领域，2020～2034年
    • 亚太地区:各给药途径，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各类型，2020～2034年
    • 中东·非洲:各治疗领域，2020～2034年
    • 中东·非洲:各给药途径，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲
  • 南美
    • 南美:各类型，2020～2034年
    • 南美:各治疗领域，2020～2034年
    • 南美:各给药途径，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第9章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第10章 企业简介

  • Arvinas
  • Kymera Therapeutics
  • Nurix Therapeutics
  • C4 Therapeutics
  • Foghorn Therapeutics
  • Zymeworks
  • Bristol-Myers Squibb
  • Pfizer
  • AbbVie
  • Molteni Farmaceutici
Product Code: PM5247

The global targeted protein degradation market size is expected to reach USD 3547.91 million by 2034, according to a new study by Polaris Market Research. The report "Targeted Protein Degradation Market Size, Share, Trends, Industry Analysis Report: By Type, Therapeutic Area (Inflammatory Disorders, Neurological Disorders, Oncological Disorders, Respiratory Disorders, and Others), Route of Administration, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The targeted protein degradation (TPD) market is experiencing significant growth, driven by advances in precision medicine and increased investments in biotechnology. A key driver is the potential of TPD to target previously "undruggable" proteins, opening new therapeutic avenues for complex diseases such as cancer and neurodegenerative disorders.

Opportunities in this market are expected to rise during the forecast period as pharmaceutical companies collaborate with academic institutions and tech firms to develop novel degraders. The emerging trend toward personalized medicine and the growing focus on small-molecule therapeutics also fuel market demand. Overall, with increasing research activities and clinical trials, the TPD market is poised for rapid expansion.

Targeted Protein Degradation Market Report Highlights:

Based on type, the proteolysis-targeting chimeric molecules (PROTACs) segment dominates the market, being widely adopted due to their ability to degrade a broad range of proteins. Degronimids are expected to witness rapid growth, driven by advancements in small-molecule therapeutics.

In terms of therapeutic area, the oncological disorders segment holds the largest share, as cancer treatments heavily rely on targeted protein degradation. The neurological disorders segment is projected to grow rapidly, with increasing research on neurodegenerative diseases such as Alzheimer's.

By route of administration, the intravenous segment dominates the market; the IV route is especially used for therapies requiring direct and controlled delivery.

North America leads the TPD market, owing to strong R&D activities and pharmaceutical investments. Asia Pacific is the fastest-growing region, driven by rising healthcare expenditure, growing biotechnology sectors, and an increasing focus on innovative therapies.

Some of the key players in the market are Arvinas, Kymera Therapeutics, and Nurix Therapeutics.

Polaris Market Research has segmented the targeted protein degradation market report on the basis of type, therapeutic area, route of administration, and region:

By Type Outlook (Revenue - USD Million, 2020-2034)

  • Degronimids
  • Immunomodulatory Drugs (IMiDs)
  • Proteolysis-Targeting Chimeric Molecules (PROTACs)
  • Sudden Acquired Retinal Degeneration Syndrome (SARDs)
  • Selective Estrogen Receptor Degraders (SERDs)
  • Others

By Therapeutic Area Outlook (Revenue - USD Million, 2020-2034)

  • Inflammatory Disorders
  • Neurological Disorders
  • Oncological Disorders
  • Respiratory Disorders
  • Others

By Route of Administration Outlook (Revenue - USD Million, 2020-2034)

  • Oral
  • Intravenous
  • Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Targeted Protein Degradation Market Insights

  • 4.1. Targeted Protein Degradation Market - Market Snapshot
  • 4.2. Targeted Protein Degradation Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Expansion in Oncology Applications
      • 4.2.1.2. Rise in Neurological Disorder Treatments
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Complexity of Drug Development and Clinical Validation
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Targeted Protein Degradation Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Targeted Protein Degradation Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • 5.3. Degronimids
    • 5.3.1. Global Targeted Protein Degradation Market, by Degronimids, by Region, 2020-2034 (USD Million)
  • 5.4. Immunomodulatory Drugs (IMiDs)
    • 5.4.1. Global Targeted Protein Degradation Market, by Immunomodulatory Drugs (IMiDs), by Region, 2020-2034 (USD Million)
  • 5.5. Proteolysis-Targeting Chimeric Molecules (PROTACs)
    • 5.5.1. Global Targeted Protein Degradation Market, by Proteolysis-Targeting Chimeric Molecules (PROTACs), by Region, 2020-2034 (USD Million)
  • 5.6. Sudden Acquired Retinal Degeneration Syndrome (SARDs)
    • 5.6.1. Global Targeted Protein Degradation Market, by Sudden Acquired Retinal Degeneration Syndrome (SARDs), by Region, 2020-2034 (USD Million)
  • 5.7. Selective Estrogen Receptor Degraders (SERDs)
    • 5.7.1. Global Targeted Protein Degradation Market, by Selective Estrogen Receptor Degraders (SERDs), by Region, 2020-2034 (USD Million)
  • 5.8. Others
    • 5.8.1. Global Targeted Protein Degradation Market, by Others, by Region, 2020-2034 (USD Million)

6. Global Targeted Protein Degradation Market, by Therapeutic Area

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • 6.3. Inflammatory Disorders
    • 6.3.1. Global Targeted Protein Degradation Market, by Inflammatory Disorders, by Region, 2020-2034 (USD Million)
  • 6.4. Neurological Disorders
    • 6.4.1. Global Targeted Protein Degradation Market, by Neurological Disorders, by Region, 2020-2034 (USD Million)
  • 6.5. Oncological Disorders
    • 6.5.1. Global Targeted Protein Degradation Market, by Oncological Disorders, by Region, 2020-2034 (USD Million)
  • 6.6. Respiratory Disorders
    • 6.6.1. Global Targeted Protein Degradation Market, by Respiratory Disorders, by Region, 2020-2034 (USD Million)
  • 6.7. Others
    • 6.7.1. Global Targeted Protein Degradation Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Targeted Protein Degradation Market, by Route of Administration

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • 7.3. Oral
    • 7.3.1. Global Targeted Protein Degradation Market, by Oral, by Region, 2020-2034 (USD Million)
  • 7.4. Intravenous
    • 7.4.1. Global Targeted Protein Degradation Market, by Intravenous, by Region, 2020-2034 (USD Million)
  • 7.5. Others
    • 7.5.1. Global Targeted Protein Degradation Market, by Others, by Region, 2020-2034 (USD Million)

8. Global Targeted Protein Degradation Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Targeted Protein Degradation Market Assessment, By Geography, 2020-2034 (USD Million)
  • 8.3. Targeted Protein Degradation Market - North America
    • 8.3.1. North America: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
    • 8.3.2. North America: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 8.3.3. North America: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.3.4. Targeted Protein Degradation Market - US
      • 8.3.4.1. US: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.3.4.2. US: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.3.4.3. US: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.3.5. Targeted Protein Degradation Market - Canada
      • 8.3.5.1. Canada: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.3.5.2. Canada: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.3.5.3. Canada: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • 8.4. Targeted Protein Degradation Market - Europe
    • 8.4.1. Europe: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
    • 8.4.2. Europe: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 8.4.3. Europe: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.4.4. Targeted Protein Degradation Market - UK
      • 8.4.4.1. UK: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.4.4.2. UK: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.4.4.3. UK: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.4.5. Targeted Protein Degradation Market - France
      • 8.4.5.1. France: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.4.5.2. France: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.4.5.3. France: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.4.6. Targeted Protein Degradation Market - Germany
      • 8.4.6.1. Germany: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.4.6.2. Germany: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.4.6.3. Germany: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.4.7. Targeted Protein Degradation Market - Italy
      • 8.4.7.1. Italy: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.4.7.2. Italy: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.4.7.3. Italy: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.4.8. Targeted Protein Degradation Market - Spain
      • 8.4.8.1. Spain: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.4.8.2. Spain: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.4.8.3. Spain: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.4.9. Targeted Protein Degradation Market - Netherlands
      • 8.4.9.1. Netherlands: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.4.9.2. Netherlands: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.4.9.3. Netherlands: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.4.10. Targeted Protein Degradation Market - Russia
      • 8.4.10.1. Russia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.4.10.2. Russia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.4.10.3. Russia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.4.11. Targeted Protein Degradation Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.4.11.2. Rest of Europe: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.4.11.3. Rest of Europe: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • 8.5. Targeted Protein Degradation Market - Asia Pacific
    • 8.5.1. Asia Pacific: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
    • 8.5.2. Asia Pacific: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 8.5.3. Asia Pacific: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.5.4. Targeted Protein Degradation Market - China
      • 8.5.4.1. China: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.5.4.2. China: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.5.4.3. China: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.5.5. Targeted Protein Degradation Market - India
      • 8.5.5.1. India: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.5.5.2. India: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.5.5.3. India: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.5.6. Targeted Protein Degradation Market - Malaysia
      • 8.5.6.1. Malaysia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.5.6.2. Malaysia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.5.6.3. Malaysia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.5.7. Targeted Protein Degradation Market - Japan
      • 8.5.7.1. Japan: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.5.7.2. Japan: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.5.7.3. Japan: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.5.8. Targeted Protein Degradation Market - Indonesia
      • 8.5.8.1. Indonesia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.5.8.2. Indonesia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.5.8.3. Indonesia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.5.9. Targeted Protein Degradation Market - South Korea
      • 8.5.9.1. South Korea: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.5.9.2. South Korea: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.5.9.3. South Korea: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.5.10. Targeted Protein Degradation Market - Australia
      • 8.5.10.1. Australia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.5.10.2. Australia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.5.10.3. Australia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.5.11. Targeted Protein Degradation Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • 8.6. Targeted Protein Degradation Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
    • 8.6.2. Middle East & Africa: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 8.6.3. Middle East & Africa: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.6.4. Targeted Protein Degradation Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.6.4.2. Saudi Arabia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.6.4.3. Saudi Arabia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.6.5. Targeted Protein Degradation Market - UAE
      • 8.6.5.1. UAE: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.6.5.2. UAE: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.6.5.3. UAE: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.6.6. Targeted Protein Degradation Market - Israel
      • 8.6.6.1. Israel: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.6.6.2. Israel: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.6.6.3. Israel: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.6.7. Targeted Protein Degradation Market - South Africa
      • 8.6.7.1. South Africa: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.6.7.2. South Africa: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.6.7.3. South Africa: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.6.8. Targeted Protein Degradation Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • 8.7. Targeted Protein Degradation Market - Latin America
    • 8.7.1. Latin America: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
    • 8.7.2. Latin America: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 8.7.3. Latin America: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.7.4. Targeted Protein Degradation Market - Mexico
      • 8.7.4.1. Mexico: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.7.4.2. Mexico: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.7.4.3. Mexico: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.7.5. Targeted Protein Degradation Market - Brazil
      • 8.7.5.1. Brazil: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.7.5.2. Brazil: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.7.5.3. Brazil: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.7.6. Targeted Protein Degradation Market - Argentina
      • 8.7.6.1. Argentina: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.7.6.2. Argentina: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.7.6.3. Argentina: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.7.7. Targeted Protein Degradation Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.7.7.2. Rest of Latin America: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.7.7.3. Rest of Latin America: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Arvinas
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Kymera Therapeutics
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Nurix Therapeutics
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. C4 Therapeutics
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Foghorn Therapeutics
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Zymeworks
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Bristol-Myers Squibb
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Pfizer
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. AbbVie
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Molteni Farmaceutici
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables:

  • Table 1 Global Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 2 Global Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 3 Global Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 4 North America: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 5 North America: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 6 North America: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 7 US: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 8 US: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 9 US: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 10 Canada: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 11 Canada: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 12 Canada: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 13 Europe: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 14 Europe: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 15 Europe: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 16 UK: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 17 UK: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 18 UK: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 19 France: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 20 France: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 21 France: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 22 Germany: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 23 Germany: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 24 Germany: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 25 Italy: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 26 Italy: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 27 Italy: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 28 Spain: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 29 Spain: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 30 Spain: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 31 Netherlands: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 32 Netherlands: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 33 Netherlands: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 34 Russia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 35 Russia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 36 Russia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 37 Rest of Europe: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 38 Rest of Europe: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 39 Rest of Europe: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 40 Asia Pacific: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 41 Asia Pacific: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 42 Asia Pacific: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 43 China: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 44 China: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 45 China: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 46 India: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 47 India: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 48 India: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 49 Malaysia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 50 Malaysia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 51 Malaysia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 52 Japan: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 53 Japan: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 54 Japan: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 55 Indonesia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 56 Indonesia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 57 Indonesia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 58 South Korea: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 59 South Korea: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 60 South Korea: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 61 Australia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 62 Australia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 63 Australia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 64 Rest of Asia Pacific: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 65 Rest of Asia Pacific: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 66 Rest of Asia Pacific: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 67 Middle East & Africa: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 68 Middle East & Africa: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 69 Middle East & Africa: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 70 Saudi Arabia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 71 Saudi Arabia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 72 Saudi Arabia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 73 UAE: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 74 UAE: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 75 UAE: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 76 Israel: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 77 Israel: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 78 Israel: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 79 South Africa: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 80 South Africa: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 81 South Africa: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 82 Rest of Middle East & Africa: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 83 Rest of Middle East & Africa: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 84 Rest of Middle East & Africa: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 85 Latin America: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 86 Latin America: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 87 Latin America: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 88 Mexico: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 89 Mexico: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 90 Mexico: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 91 Brazil: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 92 Brazil: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 93 Brazil: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 94 Argentina: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 95 Argentina: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 96 Argentina: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 97 Rest of Latin America: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 98 Rest of Latin America: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 99 Rest of Latin America: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • List of Figures:
  • Figure 1. Global Targeted Protein Degradation Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Targeted Protein Degradation Market, by Type, 2024 & 2034 (USD Million)
  • Figure 8. Market by Therapeutic Area
  • Figure 9. Global Targeted Protein Degradation Market, by Therapeutic Area, 2024 & 2034 (USD Million)
  • Figure 10. Market by Route of Administration
  • Figure 11. Global Targeted Protein Degradation Market, by Route of Administration, 2024 & 2034 (USD Million)